NCT04865367

Brief Summary

To develop a deeper understanding of endometrial-embryo crosstalk through basic research, uncover therapeutic targets and to improve reproductive outcome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 26, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 29, 2021

Completed
6 months until next milestone

Study Start

First participant enrolled

November 4, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 16, 2023

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2023

Completed
Last Updated

July 17, 2024

Status Verified

July 1, 2024

Enrollment Period

1.4 years

First QC Date

April 26, 2021

Last Update Submit

July 16, 2024

Conditions

Keywords

IVFRNACa2+embryomedia

Outcome Measures

Primary Outcomes (3)

  • Change in markers of protein

    Change in markers of protein (PAR2, (p) and SGK1, NFkB, ORAI1-3 and STIM1-2 and COX2) using Western blotting

    1 day

  • Change in peak and slope levels of intracellular calcium

    Change in peak and slope levels of intracellular calcium

    1 day

  • Change in morphohology of cells after incubation with embryo media

    Change in morphohology of cells after incubation with embryo media

    1 day

Secondary Outcomes (3)

  • Performance of ICSI

    1 day

  • Embryo quality on day 3

    1 day

  • Embryo quality on day 5 (Gardner and Schoolcraft,1999)

    1 day

Study Arms (4)

DEG n1: euploid medium

culture media derived from euploid embryos

Other: Exposure to culture media

DEG n2: aneuploid medium

culture media derived from aneuploid embryos

Other: Exposure to culture media

DEG n3: medium arrested embryos

culture media derived from arrested embryos

Other: Exposure to culture media

DEG n4: control culture medium

pure culture media without contact to embryos

Other: Exposure to culture media

Interventions

Exposure to culture media

DEG n1: euploid mediumDEG n2: aneuploid mediumDEG n3: medium arrested embryosDEG n4: control culture medium

Eligibility Criteria

Age18 Years - 36 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale arab
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Arab ethnicity, with primary / secondary infertility, who undergo an ICSI treatment with preimplantation genetic testing for aneuploidies.

You may qualify if:

  • Couples with primary / secondary infertility who are planned to undergo ICSI treatment with PGT-A
  • Age of each partner above 18 years

You may not qualify if:

  • Couples with consanguinity (couple who is 1st or 2nd degree cousins)
  • Couples in whom the female partner has a history of:
  • Chemotherapy or radiation which impacts the ovarian reserve
  • Surgery at the ovaries / adnex region
  • Endometriosis
  • Couples in whom the male partner has a history of:
  • Chemotherapy / Radiation which impacts the semen result
  • Surgery at the testicles
  • Vasectomy
  • Surgery for reversal of vasectomy
  • Semen obtained by fine needle aspiration (FNA) or Testicular sperm extraction (TESE)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ART Fertility Clinics LLC

Abu Dhabi, 60202, United Arab Emirates

Location

Related Publications (15)

  • Wang H, Dey SK. Roadmap to embryo implantation: clues from mouse models. Nat Rev Genet. 2006 Mar;7(3):185-99. doi: 10.1038/nrg1808.

    PMID: 16485018BACKGROUND
  • Kaneko Y, Day ML, Murphy CR. Integrin beta3 in rat blastocysts and epithelial cells is essential for implantation in vitro: studies with Ishikawa cells and small interfering RNA transfection. Hum Reprod. 2011 Jul;26(7):1665-74. doi: 10.1093/humrep/der128. Epub 2011 Apr 30.

    PMID: 21531996BACKGROUND
  • Mertzanidou A, Wilton L, Cheng J, Spits C, Vanneste E, Moreau Y, Vermeesch JR, Sermon K. Microarray analysis reveals abnormal chromosomal complements in over 70% of 14 normally developing human embryos. Hum Reprod. 2013 Jan;28(1):256-64. doi: 10.1093/humrep/des362. Epub 2012 Oct 9.

    PMID: 23054067BACKGROUND
  • Teklenburg G, Salker M, Heijnen C, Macklon NS, Brosens JJ. The molecular basis of recurrent pregnancy loss: impaired natural embryo selection. Mol Hum Reprod. 2010 Dec;16(12):886-95. doi: 10.1093/molehr/gaq079. Epub 2010 Sep 16.

    PMID: 20847090BACKGROUND
  • Quenby S, Vince G, Farquharson R, Aplin J. Recurrent miscarriage: a defect in nature's quality control? Hum Reprod. 2002 Aug;17(8):1959-63. doi: 10.1093/humrep/17.8.1959.

    PMID: 12151421BACKGROUND
  • Aplin JD. Embryo implantation: the molecular mechanism remains elusive. Reprod Biomed Online. 2006 Dec;13(6):833-9. doi: 10.1016/s1472-6483(10)61032-2.

    PMID: 17169205BACKGROUND
  • Zhang S, Lin H, Kong S, Wang S, Wang H, Wang H, Armant DR. Physiological and molecular determinants of embryo implantation. Mol Aspects Med. 2013 Oct;34(5):939-80. doi: 10.1016/j.mam.2012.12.011. Epub 2013 Jan 2.

    PMID: 23290997BACKGROUND
  • Ruan YC, Guo JH, Liu X, Zhang R, Tsang LL, Dong JD, Chen H, Yu MK, Jiang X, Zhang XH, Fok KL, Chung YW, Huang H, Zhou WL, Chan HC. Activation of the epithelial Na+ channel triggers prostaglandin E(2) release and production required for embryo implantation. Nat Med. 2012 Jul;18(7):1112-7. doi: 10.1038/nm.2771.

    PMID: 22729284BACKGROUND
  • Rossier BC, Stutts MJ. Activation of the epithelial sodium channel (ENaC) by serine proteases. Annu Rev Physiol. 2009;71:361-79. doi: 10.1146/annurev.physiol.010908.163108.

    PMID: 18928407BACKGROUND
  • Marunaka Y, Niisato N. Effects of Ca(2+) channel blockers on amiloride-sensitive Na(+) permeable channels and Na(+) transport in fetal rat alveolar type II epithelium. Biochem Pharmacol. 2002 Apr 15;63(8):1547-52. doi: 10.1016/s0006-2952(02)00880-8.

    PMID: 11996897BACKGROUND
  • Salker MS, Hosseinzadeh Z, Alowayed N, Zeng N, Umbach AT, Webster Z, Singh Y, Brosens JJ, Lang F. LEFTYA Activates the Epithelial Na+ Channel (ENaC) in Endometrial Cells via Serum and Glucocorticoid Inducible Kinase SGK1. Cell Physiol Biochem. 2016;39(4):1295-306. doi: 10.1159/000447834. Epub 2016 Sep 8.

    PMID: 27606670BACKGROUND
  • Singh Y, Shi X, Zhang S, Umbach AT, Chen H, Salker MS, Lang F. Prolyl hydroxylase 3 (PHD3) expression augments the development of regulatory T cells. Mol Immunol. 2016 Aug;76:7-12. doi: 10.1016/j.molimm.2016.06.003. Epub 2016 Jun 19.

    PMID: 27331863BACKGROUND
  • Heijnen EM, Eijkemans MJ, De Klerk C, Polinder S, Beckers NG, Klinkert ER, Broekmans FJ, Passchier J, Te Velde ER, Macklon NS, Fauser BC. A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. Lancet. 2007 Mar 3;369(9563):743-749. doi: 10.1016/S0140-6736(07)60360-2.

    PMID: 17336650BACKGROUND
  • Brosens JJ, Salker MS, Teklenburg G, Nautiyal J, Salter S, Lucas ES, Steel JH, Christian M, Chan YW, Boomsma CM, Moore JD, Hartshorne GM, Sucurovic S, Mulac-Jericevic B, Heijnen CJ, Quenby S, Koerkamp MJ, Holstege FC, Shmygol A, Macklon NS. Uterine selection of human embryos at implantation. Sci Rep. 2014 Feb 6;4:3894. doi: 10.1038/srep03894.

    PMID: 24503642BACKGROUND
  • Turco MY, Gardner L, Hughes J, Cindrova-Davies T, Gomez MJ, Farrell L, Hollinshead M, Marsh SGE, Brosens JJ, Critchley HO, Simons BD, Hemberger M, Koo BK, Moffett A, Burton GJ. Long-term, hormone-responsive organoid cultures of human endometrium in a chemically defined medium. Nat Cell Biol. 2017 May;19(5):568-577. doi: 10.1038/ncb3516. Epub 2017 Apr 10.

    PMID: 28394884BACKGROUND

MeSH Terms

Conditions

InfertilityInfertility, FemaleAneuploidy

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsChromosome AberrationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • BARBARA LAWRENZ, PhD

    ART Fertility Clinics LLC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Scientific Director

Study Record Dates

First Submitted

April 26, 2021

First Posted

April 29, 2021

Study Start

November 4, 2021

Primary Completion

April 16, 2023

Study Completion

May 15, 2023

Last Updated

July 17, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations